Priser
Platform
Blog
Om os
Download
Revenio Group
Revenio Group
Nasdaq Helsinki
0

Om

Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, rest of Europe, North America, and internationally. The company offers iCare IC100 and IC200 tonometers; iCare HOME, a device for self-measurement of eye pressure; and iCare TONOVET an IOP measuring on animal patients by general veterinary practitioners, veterinary ophthalmologists, and other veterinary medical personnel. It also provides imaging devices comprising iCare EIDON AF, a device with confocal retinal imaging; and DRSplus, a device for pupil imaging; and iCare COMPASS, which provides fundus perimetry with true-color confocal retinal images. In addition, the company offers Oculo, an eye care software platform, which combines clinical communication, telehealth, remote patient monitoring and data analytics capabilities. Revenio Group Oyj was incorporated in 2001 and is based in Vantaa, Finland.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I REVENIO GROUP MED ENDAVU: Køb Revenio Group ($REG) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Revenio Group, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Information

TickerREG
Antal medarbejdere229
Hjemmesidereveniogroup.fi
SektorSundhed
IndustriMedicinsk udstyr

Udbytter

0,23EUR
'16
0,25EUR
'17
0,78EUR
'18
0,28EUR
'19
0,6EUR
'20
0,32EUR
'21
Ex-udbytte-dato18. mar. 2021
Udbytteafkast1,09%